Patent ID: 8759490

Claim:
A method of treating cancer that expresses OV064 in a subject, comprising administering to the subject an anti-OV064 antibody molecule, or an antigen binding fragment thereof, wherein the anti-OV064 antibody molecule or antigen binding fragment is conjugated to a cytotoxic moiety, in an amount sufficient to reduce or inhibit the growth of the subject's cancer; wherein the anti-OV064 antibody, molecule or antigen binding fragment comprises: (a) three heavy chain complementarity determining regions (HCDR1, HCDR2 and HCDR3) comprising the following amino acid sequences: HCDR1: SEQ ID NO: 19, HCDR2: SEQ ID NO: 20, and HCDR3: SEQ ID NO: 21; and (b) three light chain complementarity determining regions (LCDR1, LCDR2 and LCDR3) comprising the following amino acid sequences: LCDR1: SEQ ID NO: 28, LCDR2: SEQ ID NO: 29, and LCDR3: SEQ ID NO: 30.